Fusion Genes

Fusion Genes

High-resolution detection of clinically actionable fusions

ATLUS Targeting, combined with long-read RNA sequencing, enables precise detection and characterisation of gene fusions by capturing full-length transcripts directly from biological samples.

This approach overcomes the limitations of conventional methods, providing accurate resolution of fusion breakpoints, isoform diversity, and complex rearrangements in a single assay.

What It Enables

Accurate Fusion Detection

High-sensitivity identification of known, novel, and low-abundance fusion events.

Structural Resolution

Precise mapping of fusion breakpoints and isoform variants to support biological interpretation.

Clinical Application

Improved patient stratification and monitoring of treatment response, minimal residual disease, and resistance.

Why It Matters

Fusion genes are key drivers of many cancers and important therapeutic targets.

ATLUS Targeting enables more confident detection and deeper understanding of fusion biology, supporting target discovery, clinical development, and precision treatment strategies.